Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Aug-24 8:07 PM View:  | Sawaf Aziz SVP & Chief Financial Officer | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 8,635 | $8.22 | $70,979.70 | (3%) 330.0K to 321.37K | (18%) |
| 22-Aug-24 8:05 PM View: | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 9,268 | $8.22 | $76,183.00 | (3%) 351.88K to 342.61K | (18%) |
| 22-Aug-24 8:09 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 15,997 | $8.22 | $131,495.00 | (< 1%) 1.94M to 1.92M | (18%) |
| 22-Aug-24 8:06 PM View: | Miller Aine SVP, Dev & Head of IRE Office | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 5,201 | $8.22 | $42,752.20 | (3%) 165.83K to 160.63K | (18%) |
| 22-Aug-24 8:03 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 20-Aug-24 | Payment of Exercise | 9,222 | $8.22 | $75,804.80 | (3%) 335.96K to 326.74K | (18%) |
| 09-Aug-24 6:02 PM View: | Samaha Eli 10% Owner | Theravance Biopharma, Inc. (TBPH) | 07-Aug-24 | Private Purchase | 999,800 | $7.80 | $7,798,440.00 | 12% 8.51M to 9.51M | |
| 09-Aug-24 6:05 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 07-Aug-24 | Grant | 3,252 | $7.83 | $25,463.20 | < 1% 1.93M to 1.94M | |
| 12-Jul-24 6:15 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 10-Jul-24 | Market Sale (Planned) | 4,000 | $9.00 | $36,000.00 | (1%) 339.96K to 335.96K | (8%) |
| 22-May-24 6:04 PM View: | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 9,268 | $9.10 | $84,338.80 | (3%) 361.15K to 351.88K | (7%) |
| 22-May-24 6:06 PM View: | Miller Aine SVP, Dev & Head of IRE Office | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 5,201 | $9.10 | $47,329.10 | (3%) 171.03K to 165.83K | (7%) |
| 22-May-24 6:10 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 15,997 | $9.10 | $145,573.00 | (< 1%) 1.95M to 1.93M | (7%) |
| 22-May-24 6:02 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 9,268 | $9.10 | $84,338.80 | (3%) 349.23K to 339.96K | (7%) |
| 22-May-24 6:08 PM View: | Sawaf Aziz SVP & Chief Financial Officer | Theravance Biopharma, Inc. (TBPH) | 20-May-24 | Payment of Exercise | 8,635 | $9.10 | $78,578.50 | (3%) 338.64K to 330.0K | (7%) |
| 17-May-24 6:01 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 15-May-24 | Grant | 2,068 | $9.85 | $20,369.80 | < 1% 1.95M to 1.95M | (1%) |
| 10-May-24 6:10 PM View: | O'Connor Donal Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 20% 53.02K to 63.55K | |
| 10-May-24 6:04 PM View: | Grant Jeremy T Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 90% 11.77K to 22.3K | |
| 10-May-24 6:09 PM View: | Mitchell Dean J Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 15% 70.02K to 80.56K | |
| 10-May-24 6:06 PM View: | Gray Susannah Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 50% 20.95K to 31.49K | |
| 10-May-24 6:01 PM View: | Smaldone Alsup Laurie Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 20% 53.79K to 64.33K | |
| 10-May-24 6:02 PM View: | Broshy Eran Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 15% 70.02K to 80.56K | |
| 10-May-24 6:12 PM View: | Pakianathan Deepika Director | Theravance Biopharma, Inc. (TBPH) | 08-May-24 | Grant | 10,537 | -- | -- | 29% 36.88K to 47.42K | |
| 03-May-24 4:19 PM View: | Samaha Eli 10% Owner | Theravance Biopharma, Inc. (TBPH) | 01-May-24 | Market Purchase | 1,499,120 | $8.75 | $13,117,300.00 | 21% 7.01M to 8.51M | 11% |
| 04-Apr-24 6:11 PM View: | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 100,000 | -- | -- | 38% 260.68K to 360.68K | |
| 04-Apr-24 6:09 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 37,500 | -- | -- | 12% 311.73K to 349.23K | |
| 04-Apr-24 6:13 PM View: | Miller Aine SVP, Dev & Head of IRE Office | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 37,500 | -- | -- | 28% 133.53K to 171.03K | |
| 04-Apr-24 6:17 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 300,000 | -- | -- | 18% 1.65M to 1.95M | |
| 04-Apr-24 6:15 PM View: | Sawaf Aziz SVP & Chief Financial Officer | Theravance Biopharma, Inc. (TBPH) | 02-Apr-24 | Grant | 100,000 | -- | -- | 42% 238.64K to 338.64K | |
| 19-Mar-24 6:06 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 15-Mar-24 | Gift | 10,900 | -- | -- | (< 1%) 1.66M to 1.65M | |
| 19-Mar-24 6:06 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 15-Mar-24 | Grant | 2,704 | $8.64 | $23,362.60 | < 1% 1.65M to 1.65M | |
| 19-Mar-24 6:06 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 15-Mar-24 | Gift | 3,900 | -- | -- | < 1% 1.65M to 1.66M | |
| 22-Feb-24 8:04 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 22-Feb-24 | Market Sale (Planned) | 1,254 | $8.71 | $10,922.30 | (< 1%) 312.99K to 311.73K | (12%) |
| 22-Feb-24 8:14 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 37,196 | $8.92 | $331,788.00 | (2%) 1.69M to 1.65M | (9%) |
| 22-Feb-24 8:11 PM View: | Sawaf Aziz SVP & Chief Financial Officer | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 17,036 | $8.92 | $151,961.00 | (7%) 255.67K to 238.64K | (9%) |
| 22-Feb-24 8:08 PM View: | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 17,595 | $8.92 | $156,947.00 | (6%) 278.28K to 260.68K | (9%) |
| 22-Feb-24 8:10 PM View: | Miller Aine SVP, Dev & Head of IRE Office | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 11,782 | $8.92 | $105,095.00 | (8%) 145.32K to 133.53K | (9%) |
| 22-Feb-24 8:06 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 19,294 | $8.92 | $172,102.00 | (6%) 334.21K to 314.92K | (9%) |
| 22-Feb-24 8:04 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 20-Feb-24 | Payment of Exercise | 18,219 | $8.92 | $162,513.00 | (6%) 331.21K to 312.99K | (9%) |
| 26-Dec-23 6:09 PM View: | Grant Jeremy T Director | Theravance Biopharma, Inc. (TBPH) | 21-Dec-23 | Grant | 11,768 | -- | -- | 100% 0 to 11.77K | |
| 22-Nov-23 6:07 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 21-Nov-23 | Market Sale (Planned) | 1,378 | $10.29 | $14,179.60 | (< 1%) 332.58K to 331.21K | 5% |
| 22-Nov-23 6:16 PM View: | Winningham Rick E Chief Executive Officer Director | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 15,804 | $10.37 | $163,887.00 | (< 1%) 1.7M to 1.69M | 6% |
| 22-Nov-23 6:14 PM View: | Sawaf Aziz SVP & Chief Financial Officer | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 6,187 | $10.37 | $64,159.20 | (2%) 261.86K to 255.67K | 6% |
| 22-Nov-23 6:11 PM View: | Grimaud Brett A. SVP, GEN COUNSEL AND SECRETARY | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 7,363 | $10.37 | $76,354.30 | (3%) 285.64K to 278.28K | 6% |
| 22-Nov-23 6:10 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 12,630 | $10.37 | $130,973.00 | (4%) 346.84K to 334.21K | 6% |
| 22-Nov-23 6:07 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 20-Nov-23 | Payment of Exercise | 7,982 | $10.37 | $82,773.30 | (2%) 340.57K to 332.58K | 6% |
| 16-Nov-23 6:16 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 14-Nov-23 | Market Sale (Planned) | 2,482 | $10.22 | $25,366.00 | (< 1%) 349.32K to 346.84K | 5% |
| 01-Nov-23 6:35 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 30-Oct-23 | Grant | 15,000 | -- | -- | 4% 334.32K to 349.32K | |
| 18-Oct-23 6:54 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 16-Oct-23 | Market Sale (Planned) | 2,482 | $9.03 | $22,412.50 | (< 1%) 336.8K to 334.32K | (8%) |
| 18-Sep-23 6:08 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 14-Sep-23 | Market Sale (Planned) | 2,482 | $9.89 | $24,547.00 | (< 1%) 339.29K to 336.8K | 2% |
| 24-Aug-23 6:05 PM View: | Farnum Rhonda SVP, Comm & Medical Affairs | Theravance Biopharma, Inc. (TBPH) | 22-Aug-23 | Market Sale (Planned) | 1,807 | $9.47 | $17,112.30 | (< 1%) 342.37K to 340.57K | (3%) |
| 22-Aug-23 6:13 PM View: | Graham Richard A SVP, RESEARCH & DEVELOPMENT | Theravance Biopharma, Inc. (TBPH) | 20-Aug-23 | Payment of Exercise | 10,461 | $9.70 | $101,472.00 | (3%) 349.75K to 339.29K | (< 1%) |
